BioSpace News Archive

Business

Rehabilitation Center Expanding into Ottawa Amidst Opioid Crisis

Addiction Treatment Company Celebrates 10th-Year as New Facility Opens

November 9, 2018
·
3 min read
Drug Development

Syros Announces Presentation of New Preclinical Data on SY-1365 in Treatment-Resistant HR-Positive Breast Cancer Cell Lines at San Antonio Breast Cancer Symposium

Syros Pharmaceuticals today announced that new preclinical data on SY-1365, its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor, will be featured in a Spotlight poster discussion session at the San Antonio Breast Cancer Symposium taking place December 4-8 in San Antonio.

November 9, 2018
·
4 min read
Policy

Nobilis Health Announces Filing of Form 12b-25

Nobilis Health Corp. announced today it has filed a Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission (the “SEC”) relating to its 10-Q for the period ended September 30, 2018.

November 9, 2018
·
5 min read
Business

MedEquities Realty Trust Reports Third Quarter 2018 Results

MedEquities Realty Trust, Inc. today announced its consolidated financial results for the quarter ended September 30, 2018 and other recent developments.

November 9, 2018
·
22 min read
Policy

American College of Chest Physicians Disagrees with FDA Decision to Approve Over-the-Counter Epinephrine for the Treatment of Asthma

The American College of Chest Physicians (CHEST) is disappointed with the FDA’s decision to approve over-the-counter epinephrine (Primatene Mist HFA) for the treatment of asthma.

November 9, 2018
·
1 min read
Biotech Bay

UnitedHealthcare and Optum Take Action to Support People Affected by Wildfires in Northern California

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by the ongoing wildfires in parts of Butte county.

November 9, 2018
·
2 min read
Business

Teamsters Ratify Agreement With American Red Cross

Wages, Benefits and More Addressed in Three-Year Contract

November 9, 2018
·
1 min read
Drug Development

Nektar Therapeutics Presents New Clinical and Preclinical Data for its Immuno-Oncology Pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical and preclinical data for its I-O pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

November 9, 2018
·
15 min read
Policy

Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie’s Humira Sales Practices

Hagens Berman Sobol Shapiro LLP reminds investors in AbbVie Inc. (NYSE: ABBV) of the Firm’s ongoing investigation of AbbVie’s Humira sales practices.

November 9, 2018
·
2 min read
BioCapital

FDA Decision to Approve Primatene Mist Endangers Asthma Patients, According to Allergy & Asthma Network and Asthma Community Stakeholders

A group of asthma community stakeholders released a joint statement today expressing deep concern over the Food and Drug Administration’s (FDA) decision to approve Primatene Mist as an over-the-counter (OTC) treatment for mild, intermittent asthma.

November 9, 2018
·
6 min read